Selectis Health (GBCS) Liabilities and Shareholders Equity (2011 - 2025)

Selectis Health has disclosed Liabilities and Shareholders Equity across 15 years of filings, most recently posting $32.6 million for Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $32.6 million, down 2.6% year-over-year; the trailing twelve-month figure through Dec 2025 was $134.0 million (down 6.71% YoY), and the FY2025 annual result was $32.6 million, down 2.6% from the prior year.
• Liabilities and Shareholders Equity came in at $32.6 million for Q4 2025 at Selectis Health, down from $33.3 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $48.7 million in Q1 2023 to a low of $32.6 million in Q4 2025.
• The 5-year median for Liabilities and Shareholders Equity is $42.4 million (2022), against an average of $41.1 million.
• Across the five-year window, Liabilities and Shareholders Equity rose 11.73% in 2021 and decreased 21.75% in 2024, its largest moves.
• Selectis Health's Liabilities and Shareholders Equity stood at $46.9 million in 2021, then dropped by 9.45% to $42.5 million in 2022, then fell by 4.28% to $40.7 million in 2023, then dropped by 17.76% to $33.4 million in 2024, then retreated by 2.6% to $32.6 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $32.6 million (Q4 2025), $33.3 million (Q3 2025), and $33.6 million (Q2 2025), per Business Quant data.